The role and clinical effectiveness of multimodality imaging in the management of cardiac complications of cancer and cancer therapy

• Published in: Journal of nuclear cardiology 2016-08, Vol.23 (4), p.856-884
• Main Authors: Russell, Raymond R., Alexander, Jonathan, Jain, Diwakar, Poornima, Indu G., Srivastava, Ajay V., Storozynsky, Eugene, Schwartz, Ronald G.
• Format: Article
• Language: English
• Subjects: Antineoplastic Agents - adverse effects; ASNC Information Statement; cancer therapy; cardiac complications; Cardiac Imaging Techniques - methods; cardio-oncology; Cardiology; Evidence-Based Medicine; Heart Diseases - diagnostic imaging; Heart Diseases - etiology; Humans; Imaging; Medicine; Medicine & Public Health; Multimodal Imaging - methods; Multimodality imaging; Nuclear Medicine; Radiation Injuries - diagnostic imaging; Radiation Injuries - etiology; Radiology; Radiotherapy - adverse effects; Tomography, Emission-Computed - methods
• ISSN: 1071-3581; 1532-6551
• DOI: 10.1007/s12350-016-0538-8

With the increasing number of individuals living with a current or prior diagnosis of cancer, it is important for the cardiovascular specialist to recognize the various complications of cancer and its therapy on the cardiovascular system. This is true not only for established cancer therapies, such as anthracyclines, that have well established cardiovascular toxicities, but also for the new targeted therapies that can have “off target” effects in the heart and vessels. The purpose of this informational statement is to provide cardiologists, cardiac imaging specialists, cardio-oncologists, and oncologists an understanding of how multimodality imaging may be used in the diagnosis and management of the cardiovascular complications of cancer therapy. In addition, this document is meant to provide useful general information concerning the cardiovascular complications of cancer and cancer therapy as well as established recommendations for the monitoring of specific cardiotoxic therapies.